Pharmacological and clinical aspects of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction

GAFAROV Rushen Refatovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2024-yil

Annotatsiya

Erectile dysfunction (ED) is an important health problem in men associated with reduced quality of life. Implementation of phosphodiesterase type 5 inhibitors (PDE-5 Is) has revolutionized the management of patients with ED and PDE-5Is are currently considered first-line therapy of ED. This paper describes characteristics of the pharmacokinetics, pharmacodynamics and possible clinical side effects of medications from the PDE-5 Is group. PDE-5Is discussed in the article include sildenafil, tadalafil, vardenafil, udenafil, avanafil, lodenafil, mirodenafil, youkenafil, SLx-2101 and simmerafil.

Maqola ma’lumotlari
MualliflarGAFAROV Rushen Refatovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
NashriyotТошкент давлат стоматалогия институти, , «Expert Lawyers» MЧЖ
ISSN2181-9300
Nashr sanasi2024-09-04
Jild9
Son3
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-27

Maqolaning asl sahifasi

Kalit so‘zlar

ингибиторы фосфодиэстеразы 5 типа, эректильная дисфункция, фармакокинетика, фармакодинамика, побочные эффекты, phosphodiesterase type 5 inhibitors, erectile dysfunction, pharmacokinetics, pharmacodynamics, side effects, fosfodiesteraza 5-turi ingibitorlari, erektil disfunksiya, farmakokinetika, farmakodinamika, nojo'ya ta'sirlar

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAGAFAROV Rushen Refatovich (2024). PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 9(3). https://tadqiqot.uz/index.php/biomedicine/article/view/10089
GOST (OAK)GAFAROV Rushen Refatovich PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. – 2024. – T. 9, № 3.
MLAGAFAROV Rushen Refatovich. “PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 9(3), 2024. https://tadqiqot.uz/index.php/biomedicine/article/view/10089
ChicagoGAFAROV Rushen Refatovich. “PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 9(3) (2024). https://tadqiqot.uz/index.php/biomedicine/article/view/10089
HarvardGAFAROV Rushen Refatovich (2024) ‘PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION’, Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 9(3). https://tadqiqot.uz/index.php/biomedicine/article/view/10089
BibTeX
@article{gafarovrushenrefatovich2024,
  title = {PHARMACOLOGICAL AND CLINICAL ASPECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION},
  author = {GAFAROV Rushen Refatovich},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year = {2024},
  volume = {9},
  number = {3},
  url = {https://tadqiqot.uz/index.php/biomedicine/article/view/10089}
}

Boshqa maqola uchun iqtibos tayyorlash

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar · 2024-yil arxivi

GAFAROV Rushen Refatovich — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari